Medical Weight Optimization
Medical Weight Optimization
Medical weight optimization is not simply about appetite suppression. It is about improving metabolic function, reducing cardiovascular risk factors, supporting hormone regulation, and protecting long-term health.
At The Royal Treatment, GLP-1 therapy is delivered with precision, structure, and expert clinical oversight to ensure safety, sustainability, and measurable outcomes.
GLP-1 Therapy
Structured. Supervised. Evidence-Based.
GLP-1 medications support metabolic health by regulating appetite, insulin response, satiety, and overall hormonal balance. These treatments are clinically studied for medical weight loss, insulin resistance management, and long-term metabolic optimization.
GLP-1 therapy works by mimicking the body’s natural incretin hormones to improve blood sugar control, reduce food cravings, slow gastric emptying, and promote sustainable fat reduction rather than rapid weight cycling.
These medications are most effective when combined with medical oversight, structured dosing, and long-term planning.
At The Royal Treatment, GLP-1 therapy is delivered as part of a medically supervised program, not a volume-based prescription service. Our approach prioritizes patient safety, evidence-based obesity medicine, and long-term cardiometabolic health.
Semaglutide
Semaglutide is a GLP-1 receptor agonist approved for chronic weight management and type 2 diabetes support. It works by targeting appetite centers in the brain and improving metabolic signaling.
Semaglutide:
- Reduces appetite
- Slows gastric emptying
- Improves insulin sensitivity
- Assists with blood glucose regulation
Best suited for:
- Patients seeking steady weight reduction
- Individuals new to GLP-1 therapy
- Patients focused on metabolic stabilization
- Those beginning a structured medical weight loss program
Semaglutide is often ideal for patients who prefer a gradual, sustainable approach to body composition improvement.
Tirzepatide
Tirzepatide is a dual GLP-1 and GIP receptor agonist used in advanced medical weight management and metabolic therapy.
In addition to GLP-1 effects, it enhances metabolic efficiency through dual hormone signaling, influencing both appetite regulation and energy utilization.
Tirzepatide may provide:
- Greater appetite suppression
- Enhanced insulin sensitivity
- Stronger body composition shifts
- Improved glycemic control
Best suited for:
- Patients with insulin resistance
- Those with higher BMI
- Patients who have plateaued on semaglutide
- Individuals seeking a more aggressive metabolic
- Patients requiring intensified metabolic intervention
Tirzepatide may be appropriate for individuals needing enhanced metabolic correction under close medical supervision.
Program Pricing
All programs include medication and clinical oversight within a structured obesity medicine framework.
Semaglutide Program
- Initial medical evaluation
- Dose titration
- Ongoing monitoring
- Quarterly follow-ups
- Secure messaging
- Side effect management
- Cardiometabolic risk review
- Metabolic health tracking
- Laboratory testing
- Nutritional supplements
- Additional injectable therapies
- Lifestyle coaching outside medical scope
Labs are billed separately.
Tirzepatide Program
- Initial medical evaluation
- Dose titration
- Ongoing monitoring
- Quarterly follow-ups
- Secure messaging
- Side effect management
- Cardiometabolic risk review
- Metabolic health tracking
Includes all components above with tirzepatide therapy and advanced metabolic management support.
What Is Not Included
- Laboratory testing
- Nutritional supplements
- Additional injectable therapies
- Lifestyle coaching outside medical scope
Labs are billed separately.